Home » Topics » Regulatory

Regulatory
RSS

Asahi Kasei Pharma clear to market osteoporosis therapy in Japan

Sep. 27, 2011

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

European approval of Removab broadened

Sep. 21, 2011

FDA approves Prolia for new indications

Sep. 20, 2011

Ono Pharmaceutical secures new Japanese approval for Glactiv

Sep. 19, 2011

Vibativ approved in Europe

Sep. 15, 2011

Ono Pharmaceutical set to launch Corebeta in Japan

Sep. 14, 2011

Novartis gains E.U. approval for Votubia

Sep. 8, 2011

European Commission grants PUMA for Buccolam

Sep. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...